# Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.

> **NCT02172547** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 10821 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Spiriva

## Key facts

- **NCT ID:** NCT02172547
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2007-01
- **Final completion:** —
- **Target enrollment:** 10821 (ACTUAL)
- **Last updated:** 2014-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02172547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02172547, "Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02172547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*